FDA compounder NDC directory

Browse every current FDA compounder source row, including records that do not contain a usable NDC.

Compounder NDC directory#

Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.

Compounder directory page 1 of 1 · 13 matching rows.

Establishment, FEI, Product NDC table
Establishment	FEI	Product NDC	Package NDC	Brand	Nonproprietary name	Active ingredients	Period	Normalization	Source date
Hybrid Pharma	079665742	26436-5608	26436-5608-2		Semaglutide	2.5 mg/1 mL	2026-1	valid	2026-10-06
Hybrid Pharma		26436-5608	26436-5608-2	SEMAGLUTIDE	SEMAGLUTIDE	2.5 mg/1 mL	2026-1	valid	2026-09-18
Hybrid Pharma	079665742	26436-5608	26436-5608-2		Semaglutide	2.5 mg/1 mL	2025-1	valid	2026-10-06
Hybrid Pharma		26436-5608	26436-5608-2	SEMAGLUTIDE	SEMAGLUTIDE	2.5 mg/1 mL	2025-1	valid	2026-09-18
Hybrid Pharma	079665742	26436-5608	26436-5608-3		Semaglutide	2.5 mg/1 mL	2024-2	valid	2026-10-06
Hybrid Pharma	079665742	26436-5608	26436-5608-2		Semaglutide	2.5 mg/1 mL	2024-2	valid	2026-10-06
Hybrid Pharma	079665742	26436-5608	26436-5608-1		Semaglutide	2.5 mg/1 mL	2024-2	valid	2026-10-06
Hybrid Pharma	079665742	26436-5608	26436-5608-4		Semaglutide	2.5 mg/1 mL	2024-2	valid	2026-10-06
Hybrid Pharma		26436-5608	26436-5608-3	SEMAGLUTIDE	SEMAGLUTIDE	2.5 mg/1 mL	2024-2	valid	2026-09-18
Hybrid Pharma		26436-5608	26436-5608-2	SEMAGLUTIDE	SEMAGLUTIDE	2.5 mg/1 mL	2024-2	valid	2026-09-18
Hybrid Pharma		26436-5608	26436-5608-1	SEMAGLUTIDE	SEMAGLUTIDE	2.5 mg/1 mL	2024-2	valid	2026-09-18
Hybrid Pharma		26436-5608	26436-5608-4	SEMAGLUTIDE	SEMAGLUTIDE	2.5 mg/1 mL	2024-2	valid	2026-09-18
Hybrid Pharma	079665742	26436-5608	26436-5608-2		Semaglutide	2.5 mg/1 mL	2024-1	valid	2026-10-06